Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A Review

被引：2
|
作者：
Kyriakopoulos, Christos E. [1 ]
Liu, Glenn [1 ]
机构：
[1] Univ Wisconsin, Carbone Canc Ctr, 600 Highland Ave, Madison, WI 53792 USA
来源：
CANCER JOURNAL | 2016年 / 22卷 / 05期
关键词：
Chemohormonal; Docetaxel; Hormone-sensitive; Prostate cancer; ANDROGEN-DEPRIVATION THERAPY; DOCETAXEL; SURVIVAL; MITOXANTRONE; PREDNISONE; FLUTAMIDE; MEN;
D O I：
10.1097/PPO.0000000000000215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Ever since the critical role of androgen deprivation therapy for the treatment of metastatic prostate cancer was established, several trials aimed to show an improved outcome with the early introduction of chemotherapy in metastatic disease. Until recently, all these trialsincluding the GETUG-AFU 15 trialfailed to confirm an improvement in survival. The recently published CHAARTED and STAMPEDE trials showed a striking benefit and changed the standard of care for patients with newly diagnosed metastatic prostate cancer. We summarize the evidence that emerged from these trials that support the use of combined chemohormonal therapy in metastatic hormone-sensitive prostate cancer.
引用
收藏
页码：322 / 325
页数：4
相关论文
共 50 条
  • [1] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
    Ciccarese, Chiara
    Santoni, Matteo
    Massari, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 286 - 286
  • [2] Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Sweeney, Christopher J.
    Chen, Yu-Hui
    Carducci, Michael
    Liu, Glenn
    Jarrard, David F.
    Eisenberger, Mario
    Wong, Yu-Ning
    Hahn, Noah
    Kohli, Manish
    Cooney, Matthew M.
    Dreicer, Robert
    Vogelzang, Nicholas J.
    Picus, Joel
    Shevrin, Daniel
    Hussain, Maha
    Garcia, Jorge A.
    DiPaola, Robert S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (08): : 737 - 746
  • [3] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer REPLY
    Garcia, Jorge A.
    Sweeney, Christopher
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 287 - 287
  • [4] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Mathieu, Romain
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
  • [5] Re: Chemohormonal Therapy in Metastatic Hormone-sensitive Prostate Cancer
    de Reijke, Theo
    EUROPEAN UROLOGY, 2016, 69 (01) : 178 - 178
  • [6] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Murphy, Declan G.
    Zargar, Homayoun
    EUROPEAN UROLOGY, 2016, 69 (03) : 540 - 540
  • [7] Chemohormonal therapy for metastatic hormone-sensitive prostate cancer: An Asian perspective
    Teoh, Jeremy Yuen-Chun
    Ng, Chi-Fai
    Poon, Darren Ming-Chun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 5 - 8
  • [8] Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer: a Cochrane Review
    Sathianathen, Niranjan J.
    Philippou, Yiannis A.
    Kuntz, Gretchen M.
    Konety, Badrinath R.
    Gupta, Shilpa
    Lamb, Alastair D.
    Dahm, Philipp
    BJU INTERNATIONAL, 2019, 124 (03) : 370 - 372
  • [9] Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer
    Sathianathen, Niranjan J.
    Philippou, Yiannis A.
    Kuntz, Gretchen M.
    Konety, Badrinath R.
    Gupta, Shilpa
    Lamb, Alastair D.
    Dahm, Philipp
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (10):
  • [10] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 195 (01): : 94 - 94
12345